Published in Thromb Haemost on February 12, 1991
Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood (2008) 2.03
Diabetes, insulin, and development of acute lung injury. Crit Care Med (2009) 1.26
Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol Med (1996) 1.10
Synergistic and multidimensional regulation of plasminogen activator inhibitor type 1 expression by transforming growth factor type β and epidermal growth factor. J Biol Chem (2012) 0.79
Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest (1983) 4.70
Does diabetes therapy influence the risk of cancer? Diabetologia (2009) 3.66
Structure of Rhodopseudomonas sphaeroides R-26 reaction center. FEBS Lett (1986) 3.28
A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol (1987) 2.63
Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med (1990) 2.25
Evaluation of "HemoCue," a new device for determining hemoglobin. Clin Chem (1986) 2.23
Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. Diabetologia (2007) 2.16
Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics. Lancet (1979) 2.01
Smoking induces insulin resistance--a potential link with the insulin resistance syndrome. J Intern Med (1993) 2.01
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost (2012) 1.74
Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1997) 1.73
Phycocyanobilin. Structure and exchange studies by nuclear magnetic resonance and its mode of attachment in phycocyanin. A model for phytochrome. Biochemistry (1968) 1.67
Evidence for lactate production by human adipose tissue in vivo. Diabetologia (1990) 1.63
Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg (1993) 1.62
The organization and myofilament array of insect visceral muscles. J Cell Sci (1966) 1.57
Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg (1993) 1.57
Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? Diabetologia (2007) 1.56
Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun (2001) 1.54
The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients--the EUGENE2 study. Diabetologia (2008) 1.53
Deep vein thrombosis of the axillary-subclavian veins: epidemiologic data, effects of different types of treatment and late sequelae. Eur J Vasc Surg (1988) 1.53
Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes (1996) 1.52
Lipid intolerance in smokers. J Intern Med (1995) 1.48
Angiotensin I: metabolism by plasma membrane of lung. Science (1972) 1.45
Isolation and characterization of cells from rat adipose tissue developing into adipocytes. J Lipid Res (1978) 1.43
Comparison of seven formulae and isoelectrofocusing for determination of intrathecally produced IgG in neurological diseases. Ann Clin Biochem (1992) 1.42
Characterization of inhibitors to FVIII with an ELISA in congenital and acquired haemophilia A. Haemophilia (2002) 1.42
Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport. FASEB J (2001) 1.41
Electron microscopy of endothelial and epithelial components of the lungs: correlations of structure and function. Fed Proc (1973) 1.40
Fat cell metabolism in different regions in women. Effect of menstrual cycle, pregnancy, and lactation. J Clin Invest (1985) 1.40
An approach to study the viral safety of plasma-derived products in previously treated, non-infected patients. Haemophilia (2001) 1.40
[A complication in Budd-Chiari syndrome. Heparin therapy caused thrombocytopenia]. Lakartidningen (1994) 1.39
Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. J Clin Endocrinol Metab (1999) 1.37
Inactivation of tissue plasminogen activator in plasma. Demonstration of a complex with a new rapid inhibitor. J Biol Chem (1984) 1.36
Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized. Br J Haematol (1999) 1.32
Characterization by microdialysis of intracellular glucose level in subcutaneous tissue in humans. Am J Physiol (1988) 1.30
Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J Intern Med (1991) 1.30
Counter-regulation of insulin-stimulated glucose transport by catecholamines in the isolated rat adipose cell. J Biol Chem (1984) 1.29
Body fat and adipose tissue cellularity in infants: a longitudinal study. Metabolism (1977) 1.28
Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes (2003) 1.28
Regional adipose tissue cellularity in relation to metabolism in young and middle-aged women. Metabolism (1975) 1.28
Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest (1997) 1.27
Exocytosis in the adrenal medulla demonstrated by freeze-etching. Science (1973) 1.25
Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. Diabetologia (2008) 1.25
Metabolism of adenosine 5'-monophosphate during circulation through the lungs. Trans Assoc Am Physicians (1971) 1.25
Glycerol production in subcutaneous adipose tissue in lean and obese humans. J Clin Invest (1992) 1.24
Endothelial projections as revealed by scanning electron microscopy. Science (1971) 1.24
Effect of beta-adrenoceptor blockade on exercise performance and metabolism. Clin Sci (Lond) (1981) 1.23
Comparison of two methods for determining human adipose cell size. J Lipid Res (1972) 1.23
Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance. Biochem Biophys Res Commun (2003) 1.23
Regional differences and effect of weight reduction on human fat cell metabolism. Eur J Clin Invest (1979) 1.22
Hemostatic and metabolic variables in women with polycystic ovary syndrome. Fertil Steril (1994) 1.22
Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion. Br Med J (Clin Res Ed) (1983) 1.22
A rapid, simple method for isolating pinocytotic vesicles and plasma membrane of lung. Biochim Biophys Acta (1971) 1.19
Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Br Med J (Clin Res Ed) (1985) 1.19
Differences in metabolic responses to beta-adrenergic stimulation after propranolol or metoprolol administration. Acta Med Scand (1979) 1.18
Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation (1996) 1.17
Glucose uptake in human adipose tissue. Metabolism (1987) 1.15
Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes (1990) 1.14
Characterization of bacterial photosynthetic reaction center crystals from Rhodopseudomonas sphaeroides R-26 by X-ray diffraction. J Mol Biol (1985) 1.14
Laboratory and field evaluation of three desktop instruments for assay of cholesterol and triglyceride. Clin Chem (1987) 1.12
Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism (1990) 1.12
Order! Order! Order in the House! DIAMAP: a road map for European diabetes research. Diabetologia (2008) 1.11
Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon? Diabetes (1999) 1.11
Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM. FASEB J (1999) 1.11
Cellularity in different regions of adipose tissue in young men and women. Metabolism (1972) 1.10
Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study. Diabetologia (2012) 1.09
Effect of cell size on lipolysis and antilipolytic action of insulin in human fat cells. J Lipid Res (1972) 1.08
The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis (1997) 1.07
AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3). Diabetologia (2010) 1.07
Metabolism of [8-L-[14C] phenylalanine]-angiotensin I in the pulmonary circulation. Biochem J (1971) 1.07
The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Thromb (1994) 1.07
[An extensive study gives a hope for better control of type 2 diabetes mellitus]. Lakartidningen (1998) 1.07
Islet hormone secretion in pancreatic cancer patients with diabetes. Pancreas (1997) 1.06
Regional adipose tissue metabolism in men and postmenopausal women. Int J Obes (1987) 1.06
Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects. Diabetologia (2004) 1.06
Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes. Ann Intern Med (1999) 1.05
Effect of cell size on lipid synthesis by human adipose tissue in vitro. J Lipid Res (1971) 1.05
The effect of PPARgamma ligands on the adipose tissue in insulin resistance. Prostaglandins Leukot Essent Fatty Acids (2005) 1.05
Effects of hyperglycemia on interdigestive gastrointestinal motility in humans. Scand J Gastroenterol (1994) 1.05
Insulin resistance in fat cells from obese Zucker rats--evidence for an impaired activation and translocation of protein kinase B and glucose transporter 4. Mol Cell Biochem (2000) 1.04
Freeze-etch studies of the plasma membrane of pulmonary endothelial cells. J Cell Biol (1973) 1.03
Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro. Diabetologia (2012) 1.03
Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia. Prostate Cancer Prostatic Dis (2008) 1.02
Insulin binding and responsiveness in fat cells from patients with reduced glucose tolerance and type II diabetes. Diabetes (1983) 1.02
Human adipose tissue in culture. VIII. Studies on the insulin-antagonistic effect of glucocorticoids. Metabolism (1979) 1.01
A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa. Thromb Haemost (1996) 1.01
Normal vaginal delivery is to be recommended for haemophilia carrier gravidae. Acta Paediatr (1994) 1.01
The role of the fibrinolytic system in deep vein thrombosis. J Lab Clin Med (1985) 1.00
The toxicity of streptolysin O for beating mammalian heart cells in tissue culture. J Exp Med (1970) 1.00
Free and total insulin as determined after precipitation with polyethylene glycol: analytical characteristics and effects of sample handling and storage. Clin Chem (1987) 1.00
Freeze-fractured lamellar body membranes of the rat lung great alveolar cell. Tissue Cell (1972) 1.00
Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes. Diabetes Obes Metab (2011) 1.00
von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis. Ann Rheum Dis (1991) 0.99
Determination of tissue plasminogen activator and its "fast" inhibitor in plasma. Clin Chem (1986) 0.99